introduct
lor
dun
pulmonair
aigu
chez
un
sujet
il
est
parfoi
difficil
de
un
syndrom
thoraciqu
aigu
sta
dune
pneumopathi
infectieus
ressembl
absenc
de
document
microbiologiqu
notr
objectif
lapport
de
la
pcr
pour
de
respiratoir
en
associ
avec
le
examen
microbiologiqu
standard
dan
la
document
microbiologiqu
de
sta
de
patient
adult
et
prospect
monocentriqu
et
observationnel
de
avril
de
sanguin
respiratoir
et
urinair
ont
avant
et
de
fin
de
cultur
et
pcr
pour
de
respiratoir
un
dan
de
sta
quatr
viru
rhinoviru
influenza
ab
sept
aureu
pneumonia
k
pneumonia
l
pneumophila
pneumonia
une
coinfect
aureu
et
influenza
b
la
pcr
une
seul
infect
l
pneumophila
si
la
significativ
plu
court
vs
jour
p
dan
le
group
de
sta
san
document
microbiologiqu
aucun
autr
n
mise
en
entr
le
group
de
sta
microbiologiqu
et
de
ceux
non
conclus
chez
le
patient
adult
lutilis
de
la
pcr
la
recherch
de
respiratoir
le
diagnost
microbiologiqu
de
sta
dan
lesquel
la
part
infectieus
est
secondair
background
differenti
acut
chest
syndrom
ac
communityacquir
pneumonia
cap
challeng
adult
present
major
sickl
cell
diseas
scd
semiolog
similar
rare
microbiolog
document
aim
assess
use
nucleic
preliminari
result
present
european
congress
clinic
microbiolog
infecti
diseas
vienna
austria
april
poster
abstract
raffetin
et
al
et
maladi
infectieus
acid
amplif
test
naat
respiratori
pathogen
combin
standard
bacteriolog
investig
febril
ac
adult
patient
present
major
scd
method
perform
prospect
monocentr
observ
studi
scd
adult
present
febril
ac
februari
april
systemat
blood
urin
respiratori
specimen
collect
antibiot
initi
cultur
urinari
antigen
test
serolog
naat
respiratori
pathogen
result
pathogen
detect
febril
ac
four
virus
rhinoviru
influenza
ab
seven
bacteria
aureu
pneumonia
k
pneumonia
l
pneumophila
pneumonia
one
mix
infect
aureu
influenza
b
naat
detect
l
pneumophila
one
case
serogroup
apart
significantli
shorter
antibiot
therapi
durat
vs
day
p
differ
observ
undocu
microbiologicallydocu
febril
ac
conclus
use
naat
detect
respiratori
pathogen
adult
present
scd
slightli
improv
microbiolog
diagnost
febril
ac
although
respiratori
infect
main
etiolog
factor
acut
chest
syndrom
one
lead
caus
hospit
death
adult
patient
present
sickl
cell
diseas
distinguish
acut
chest
syndrom
communityacquir
pneumonia
difficult
semiolog
similar
low
rate
microbiolog
document
acut
chest
syndrom
communityacquir
pneumonia
function
asplenia
sickl
cell
diseas
predispos
patient
encapsul
bacteri
infect
particularli
streptococcu
pneumonia
infect
classic
trigger
acut
chest
syndrom
use
nucleic
acid
amplif
test
naat
respiratori
pathogen
detect
improv
microbiolog
diagnost
yield
communityacquir
pneumonia
sensit
naat
superior
tradit
procedur
furthermor
widespread
use
pneumococcu
influenza
vaccin
sickl
cell
diseas
patient
may
chang
distribut
pulmonari
pathogen
howev
gener
use
naat
routin
practic
two
studi
conduct
sickl
cell
diseas
adult
present
acut
chest
syndrom
report
discrep
result
concern
microbiolog
detect
rate
respiratori
sampl
et
al
report
pathogen
episod
acut
chest
syndrom
bronchoscopi
sampl
carri
antibiot
initi
vichinski
et
al
detect
pathogen
acut
chest
syndrom
episod
mainli
chlamydophila
pneumonia
mycoplasma
pneumonia
respiratori
virus
aim
studi
assess
use
naat
combin
standard
bacteriolog
investig
microbiolog
detect
respiratori
pathogen
febril
acut
chest
syndrom
adult
present
major
sickl
cell
diseas
conduct
observ
prospect
monocentr
studi
februari
april
sickl
cell
diseas
refer
center
henri
mondor
univers
hospit
franc
center
manag
cohort
around
patient
annual
rate
hospit
acut
chest
syndrom
patient
deem
elig
enrol
present
acut
chest
syndrom
fever
strictli
c
age
year
hemoglobin
phenotyp
ss
sc
sbetathalassemia
electrophoret
analysi
hemoglobin
chain
inform
consent
obtain
patient
beforehand
diagnosi
acut
chest
syndrom
base
respiratori
symptom
chest
pain
tachypnea
cough
wheez
andor
abnorm
chest
sound
new
pulmonari
infiltr
chest
xray
radiolog
find
admiss
normal
clinic
featur
acut
chest
syndrom
new
chest
xray
ctscan
perform
hour
hospit
standard
anonym
form
use
collect
data
studi
approv
ethic
committe
iledefr
v
januari
regist
french
agenc
safeti
health
product
french
acronym
ansm
idrcb
introduc
antibiot
collect
highqual
sputum
gram
stain
cultur
blood
sampl
cultur
urin
legionella
pneumophila
serogroup
pneumococc
urinari
antigen
test
binaxnow
aler
serolog
test
mycoplasma
pneumonia
elisamedac
germani
chlamydophila
pneumonia
elisaplu
medac
igg
elisamedac
igm
germani
legionella
spp
elisazeu
scientif
posit
ifieurobio
perform
baselin
week
naat
perform
sputum
irrespect
sampl
qualiti
detect
legionella
spp
diagenod
franc
nasopharyng
swab
influenza
ab
virus
respiratori
syncyti
viru
rsv
metapneumoviru
hmpv
rhinovirusenteroviru
rhino
evcc
adenovirusbocaviru
adhbov
coronavirusparainfluenza
viru
hcovhpiv
c
pneumonia
pneumonia
bordetella
spp
respiratori
multiwel
system
rgenetm
marci
franc
white
blood
cell
count
hemoglobin
level
lactat
dehydrogenas
creactiv
protein
procalcitonin
pct
admiss
first
hour
hospit
measur
bacteri
pneumonia
except
atyp
bacteri
agent
defin
detect
gramposit
gramneg
bacteria
sputum
blood
sampl
absenc
sourc
infect
posit
pneumococc
urinari
antigen
test
chlamydophila
pneumonia
pulmonari
infect
defin
posit
serolog
presenc
igm
kinet
igg
titer
primari
infect
absenc
igm
increas
igg
titer
factor
least
four
two
week
onset
infect
igg
auml
admiss
posit
pcr
consist
reinfect
posit
pcr
nasopharyng
swab
associ
posit
serolog
serolog
c
pneumonia
match
serolog
chlamydia
trachomati
check
absenc
crossreact
mycoplasma
pneumonia
pulmonari
infect
defin
posit
serolog
presenc
igm
iga
igg
auml
kinet
igg
titer
primari
infect
absenc
igm
iga
increas
igg
titer
factor
least
four
two
week
infect
onset
consist
reinfect
posit
pcr
nasopharyng
swab
legionella
spp
pulmonari
infect
defin
posit
serolog
indirect
immunofluoresc
presenc
igm
igg
auml
admiss
posit
igm
increas
igg
titer
factor
least
four
day
later
second
titer
auml
l
pneumophila
auml
speci
posit
pcr
sputum
posit
urinari
antigen
test
l
pneumophila
serotyp
posit
cultur
sputum
blood
viral
bronchopulmonari
infect
determin
respiratori
virus
includ
multiplex
pcr
detect
nasopharyng
swab
sickl
cell
diseas
patient
treat
accord
french
guidelin
manag
acut
chest
syndrom
intraven
rehydr
multimod
analgesia
controlledreleas
morphin
need
anxieti
treatment
prevent
anticoagul
nasal
cannula
oxygen
therapi
respiratori
kinesiotherapi
incent
spirometri
patient
receiv
red
blood
cell
transfus
recommend
antimicrobi
chosen
per
european
guidelin
manag
communityacquir
pneumonia
french
guidelin
manag
acut
chest
syndrom
descript
result
express
median
rang
proport
comparison
accord
microbiologicallydocu
undocu
acut
chest
syndrom
statu
perform
use
mann
whitney
test
quantit
variabl
durat
antibiot
cours
hospit
stay
fisher
exact
test
qualit
variabl
treatment
hydroxyurea
analys
perform
use
stata
softwar
statacorp
colleg
station
tx
usa
sixtyon
patient
includ
demograph
sickl
cell
diseas
characterist
summar
tabl
characterist
acut
chest
syndrom
episod
present
tabl
main
symptom
associ
fever
chest
pain
n
tachypnea
n
vasoocclus
crisi
preced
acut
chest
syndrom
patient
mean
interv
two
day
routin
blood
work
result
patient
present
vasoocclus
crisi
typic
patient
document
bacteri
infect
elev
pct
gl
except
one
patient
pneumococc
pneumonia
gl
pct
threshold
gl
bacteri
infect
sensit
specif
respect
pct
posit
neg
predict
valu
respect
overal
differ
regard
record
variabl
observ
microbiolog
document
undocu
febril
acut
chest
syndrom
episod
variou
sampl
collect
analys
eg
blood
perform
cultur
patient
highqual
sputum
specimen
cultur
patient
sputum
specimen
legionella
spp
pcr
patient
nasopharyng
swab
multiplex
pcr
patient
urin
sampl
perform
legionella
pneumococc
urinari
antigen
test
patient
blood
sampl
c
pneumonia
pneumonia
serolog
tabl
microbiolog
characterist
febril
acut
chest
syndrom
summar
tabl
detect
follow
pathogen
patient
bacteria
seven
patient
includ
methicillinsuscept
staphylococcu
aureu
n
streptococcu
pneumonia
n
klebsiella
pneumonia
n
legionella
pneumophila
n
myco
plasma
pneumonia
n
virus
four
includ
rhinoviru
n
influenza
viru
n
one
type
one
type
b
one
coinfect
methicillinresist
staphylococcu
aureu
influenza
viru
b
multiplex
pcr
enabl
detect
five
viral
pathogen
influenza
virus
rhinovirus
respiratori
syncyti
viru
one
patient
serogroup
l
pneumophila
detect
specif
pcr
sputum
pcr
assay
c
pneumonia
pneumonia
neg
inhospit
cours
administ
treatment
summar
tabl
twentythre
patient
admit
intens
care
unit
none
die
mean
hospit
stay
day
day
bacteri
pneumonia
day
atyp
pneumonia
statist
signific
differ
observ
hospit
stay
microbiologicallydocu
undocu
acut
chest
syndrom
tabl
patient
receiv
oxygen
therapi
four
requir
mechan
ventil
red
blood
cell
transfus
administ
patient
symptomat
anaemia
hb
gdl
n
unfavor
acut
chest
syndrom
outcom
three
day
hospit
n
splenic
sequestr
n
pregnanc
n
chronic
transfus
therapi
n
empir
antibiot
cours
introduc
patient
later
adapt
accord
bacteri
detect
result
nine
patient
mean
time
initi
levofloxacin
n
piperacillintazobactam
n
oxacillin
n
linezolid
n
empir
therapi
adapt
specif
therapi
day
overal
prescrib
antibiot
amoxicillin
n
amoxicillinclavulan
acid
n
cefotaxim
n
spiramycin
n
telithromycin
n
levofloxacin
n
piperacillintazobactam
n
oxacillin
n
linezolid
n
prescrib
part
combin
therapi
mean
durat
whole
antibiot
therapi
day
statist
signific
differ
antibiot
therapi
durat
observ
microbiologicallydocu
day
undocu
day
acut
chest
syndrom
p
observ
infect
patient
hydroxyurea
without
tabl
patient
influenza
viru
infect
treat
oseltamivir
nine
patient
receiv
antibiot
therapi
present
clinic
sign
moder
inflammatori
featur
temperatur
c
crp
mgl
pct
gl
pathogen
detect
among
overal
except
signific
shorter
durat
antibiot
therapi
patient
undocu
acut
chest
syndrom
differ
regard
record
variabl
observ
microbiolog
document
undocu
febril
acut
chest
syndrom
use
naat
detect
respiratori
pathogen
combin
standard
bacteriolog
investig
slightli
increas
yield
microbiolog
diagnosi
sickl
cell
diseas
adult
present
febril
acut
chest
syndrom
especi
viral
detect
bacteri
pathogen
one
case
serotyp
legionella
pneumophila
detect
naat
signific
differ
observ
microbiologicallydocu
undocu
febril
acut
chest
syndrom
apart
statist
signific
shorter
durat
antibiot
therapi
patient
pathogen
detect
use
naat
atyp
bacteri
viral
respiratori
pathogen
consider
evalu
past
year
increas
microbiolog
diagnost
yield
enabl
earli
deescal
empir
broadspectrum
antimicrobi
prevent
emerg
bacteri
resist
potenti
side
effect
drug
interact
use
naat
albeit
perform
detect
fewer
atyp
microorgan
previous
report
studi
use
tradit
method
detect
respiratori
virus
despit
lead
pathogen
respiratori
tract
infect
despit
studi
conduct
winter
epidem
respiratori
syncyti
viru
infect
diagnos
despit
ongo
outbreak
franc
studi
period
microbiolog
diagnosi
patient
test
posit
influenza
viru
infect
thu
switch
specif
oseltamivir
treatment
could
achiev
flutarget
specif
pcr
less
expens
virus
play
role
sickl
cell
diseas
children
present
acut
chest
syndrom
less
frequent
observ
adult
overal
vaccin
coverag
cohort
higher
target
french
popul
elderli
peopl
immunocompromis
patient
respiratori
insuffici
less
influenza
infect
detect
could
due
high
flu
vaccin
coverag
detect
two
pneumococc
pneumonia
case
less
communityacquir
pneumonia
usual
report
immunocompet
adult
could
relat
conjug
antipneumococc
vaccin
effect
previous
administ
patient
bacteri
clearanc
fast
legionella
pneumonia
asymptomat
respiratori
carriag
pathogen
detect
suggest
acut
respiratori
tract
infect
differenti
upper
lower
respiratori
tract
infect
henc
need
interpret
pcr
result
accord
clinic
find
document
one
pneumonia
caus
serogroup
l
pneumophila
pcr
convers
respiratori
carriag
c
pneumonia
common
last
sever
month
therefor
microbiolog
criteria
c
pneumonia
infect
posit
pcr
serolog
latter
diagnost
definit
taken
consider
previou
studi
posit
pcr
c
pneumophila
consid
suffici
confirm
diagnosi
discrep
may
underestim
incid
c
pneumonia
respiratori
tract
infect
cohort
compar
previou
one
usual
standard
test
microbiolog
detect
lower
sensit
specif
naat
sputum
cultur
excel
specif
rather
moder
sensit
especi
administr
antibiot
blood
cultur
even
less
sensit
bacteri
pneumonia
except
sever
pneumonia
blood
cultur
posit
sampl
pneumococc
urinari
antigen
test
moder
sensit
good
specif
may
remain
posit
six
month
pneumococc
pneumonia
pneumococc
vaccin
one
patient
diagnos
pneumococc
pneumonia
base
posit
urinari
antigen
test
report
pneumococc
infect
previou
year
legionella
urinari
antigen
test
sensit
specif
detect
serogroup
l
pneumophila
franc
earli
neg
test
rule
diagnosi
posit
test
interpret
case
repeat
pneumonia
anoth
explan
low
pathogen
detect
rate
could
suboptim
qualiti
swab
sampl
success
naat
requir
correct
techniqu
sampl
could
difficult
busi
standard
healthcar
set
result
swab
test
differ
accord
sampl
site
eg
test
nasal
swab
less
sensit
nasopharyng
swab
observ
one
fals
neg
pneumonia
pcr
result
yet
posit
serolog
consist
clinic
find
pneumonia
exclud
potenti
pcr
inhibitor
hypothes
poor
qualiti
nasopharyng
swab
unfortun
control
swab
perform
guidelin
use
antibiot
acut
chest
syndrom
base
clinic
experi
orient
minim
risk
encapsul
bacteri
infect
function
asplen
sickl
cell
diseas
patient
antipneumococc
penicillinbas
antibiot
find
reveal
aureu
also
one
lead
detect
pathogen
febril
acut
chest
syndrom
sickl
cell
diseas
adult
empir
antibiot
could
broaden
amoxicillinclavulan
acid
firstlin
therapi
least
flu
epidem
macrolid
combin
betalactam
kept
sever
acut
chest
syndrom
legionella
spp
infect
suspect
recommend
studi
sever
limit
first
abl
enrol
everi
consecut
elig
patient
howev
high
incid
acut
chest
syndrom
hospit
allow
us
constitut
repres
cohort
patient
studi
period
secondli
includ
febril
acut
chest
syndrom
episod
admiss
may
exclud
initi
afebril
infect
viral
infect
sickl
cell
diseas
patient
use
take
acetaminophen
pain
given
previou
studi
around
patient
acut
chest
syndrom
febril
admiss
provid
addit
evid
clinic
featur
associ
acut
chest
syndrom
thirdli
perform
compar
studi
final
requir
specimen
obtain
patient
chest
pain
nonproduct
cough
may
underestim
incid
pathogen
naat
slightli
improv
microbiolog
diagnosi
infect
sickl
cell
diseas
adult
present
febril
acut
chest
syndrom
pathogen
detect
low
beyond
technic
limit
naat
standard
clinic
set
find
suggest
limit
role
infect
pathophysiolog
acut
chest
syndrom
howev
antibiot
larg
prescrib
acut
chest
syndrom
patient
use
atyp
bacteri
viral
pcr
could
lead
earli
deescal
antimicrobi
particularli
macrolid
consid
futur
prospect
studi
ar
collect
analyz
data
draft
articl
gm
supervis
studi
review
articl
ea
perform
biostatist
review
articl
ah
kr
rl
cg
mk
pb
collect
data
review
articl
jwd
sf
perform
microbiolog
test
review
articl
sg
supervis
studi
analyz
data
draft
review
articl
gm
sg
person
review
data
understood
statist
method
employ
efficaci
analysi
confirm
understand
analysi
method
clearli
describ
fair
way
report
result
confirm
studi
object
procedur
honestli
disclos
also
review
studi
execut
data
confirm
procedur
follow
extent
convinc
author
result
valid
generaliz
popul
similar
enrol
studi
author
declar
compet
interest
